Management of this condition has been associated with antibiotic misuse. In the latest Bench to Bedside column, clinicians offer insights on therapy indications and what the latest literature reports on the condition.
Mohamed Hisham, PharmD, BCCCP, BCIDP
Advertisement
Mohamed Hisham is a lead clinical pharmacist at Cleveland Clinic Abu Dhabi, United Arab Emirates; he works with the antimicrobial stewardship team. He is also a Clinical Assistant Professor of Medicine at Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Ohio, USA.His Twitter handle is: @HishamZenith
Articles by Mohamed Hisham, PharmD, BCCCP, BCIDP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
New Data Highlight Adult Pneumococcal Serotypes with Greater Antibiotic Resistance and Disease Burden Covered by Merck’s Vaccine
2
Oral Carbapenem Tebipenem HBr Demonstrates Non-Inferiority to IV Therapy in Phase III PIVOT-PO Trial
3
Introducing Cefiderocol Earlier in Difficult-to-Treat-Infections
4
Developing a COVID-19 Vaccine Alternative
5
